Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods

Abstract In this study, the minimal residual disease (MRD) levels in patients with multiple myeloma (MM) were assessed by comparing the new 8-color single-tube multiparameter flow cytometry method (DuraClone), which reduces the cost of antibodies and labor burden of laboratories, with the EuroFlow n...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Takeshi Yoroidaka, Kentaro Narita, Hiroyuki Takamatsu, Momoko Fujisawa, Shinji Nakao, Kosei Matsue
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/0183caa16ebe49ea857003f9cf702b0b
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!